Journal of Gastrointestinal Surgery

, Volume 16, Issue 6, pp 1171–1180 | Cite as

Resection Margin with Anatomic or Nonanatomic Hepatectomy for Liver Metastasis from Colorectal Cancer

  • Yoshihiro Inoue
  • Michihiro Hayashi
  • Koji Komeda
  • Shinsuke Masubuchi
  • Masashi Yamamoto
  • Hidenori Yamana
  • Hajime Kayano
  • Tetsunosuke Shimizu
  • Mitsuhiro Asakuma
  • Fumitoshi Hirokawa
  • Yoshiharu Miyamoto
  • Atsushi Takeshita
  • Yuro Shibayama
  • Kazuhisa Uchiyama
Original Article



When hepatectomy is used as a primary treatment for liver metastasis from colorectal cancer (CRCLM), the balance between surgical curability and functional preservation of the remnant liver is of great importance.


A total of 108 patients who underwent initial hepatectomy for CRCLM were retrospectively analyzed with respect to tumor extent, operative method, and prognosis, including recurrence.


The 1-, 2-, 3-, and 5-year overall survival rates (OS) for all patients were 90.5%, 77.8%, 63.2%, and 51.6%, respectively. Multivariate analysis indicated serum carbohydrate antigen 19-9 (CA 19-9) level after hepatectomy (<36 or ≥36 mAU/mL) and presence of recurrence as independent prognostic factors of OS (P = 0.0458 and 0.0249, respectively), and tumor depth of colorectal cancer (<se (a2) vs. ≥se (a2)) and serum CA 19-9 level after hepatectomy as the significant factors affecting disease-free survival (DFS) (P = 0.0025 and 0.00138, respectively). Neither resection margin nor type of hepatectomy (anatomic or nonanatomic) for CRCLM was a significant prognostic factor for OS or DFS or CRCLM recurrence, including intrahepatic recurrence.


In CRCLM, we believe that nonanatomic hepatectomy with narrow margin is indicated, and optimal treatment would include functional preservation of as much of the remnant liver as possible.


Liver metastasis from colorectal cancer Resection margin width Type of hepatectomy Intrahepatic recurrence 



Colorectal cancer


Liver metastasis from colorectal cancer


Carcinoembryonic antigen

CA 19-9

Carbohydrate antigen 19-9


Hepatocellular carcinoma


Aspartate aminotransferase


Alanine aminotransferase


Indocyanine green retention rate at 15 min


Hepatitis B virus


Hepatitis B virus surface antigen


Hepatitis C virus


Computed tomography


Magnetic resonance imaging


  1. 1.
    Adson MA. Resection of liver metastasis—when is it worthwhile? World J Surg 1987; 11:511-20.PubMedCrossRefGoogle Scholar
  2. 2.
    Fortner JG. Recurrence of colorectal cancer after hepatic resection. Am J Surg 1988; 155:378-82.PubMedCrossRefGoogle Scholar
  3. 3.
    Scheele J, Stangl R, Altendorf-Hofmann A, Gall FP. Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery 1991; 110:13-29.PubMedGoogle Scholar
  4. 4.
    Suzuki S, Sakaguchi T, Yokoi Y, Kurachi K, Okamoto K, Okumura T, Tsuchiya Y, Nakamura T, Konno H, Baba S, Nakamura S. Impact of repeat hepatectomy on recurrent colorectal liver metastases. Surgery 2001; 129:421-28.PubMedGoogle Scholar
  5. 5.
    Nakamura S, Suzuki S, Konno H. Resection of hepatic metastases of colorectal carcinoma: 20 years' experience. J Hep Bil Pancr Surg 1999; 1:16-22.CrossRefGoogle Scholar
  6. 6.
    Choti MA, Sitzmann JV, Tiburi MF, Sumetchotimetha W, Rangsin R, Schulicl RD, Lillemoe KD, Yeo CJ, Cameron JL. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 2002; 235:759-66.PubMedCrossRefGoogle Scholar
  7. 7.
    Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999; 230(3):309-18.PubMedCrossRefGoogle Scholar
  8. 8.
    Assumpcao L, Choti MA, Gleisner AL, Schulick RD, Swartz M, Herman J, Gearhart SL, Pawlik TM. Patterns of recurrence following liver resection for colorectal metastases. Arch Surg 2008; 143(8):743-49.PubMedCrossRefGoogle Scholar
  9. 9.
    Nordinger B, Parc R, Delva E, Quilinchini MA, Hannoun L, Huguet C. Hepatic resection for colorectal liver metastases. Influence on survival of pre-operative factors and surgery for recurrence. 80 cases. Ann Surg 1989; 205:256-63.CrossRefGoogle Scholar
  10. 10.
    Koike M, Yasui K, Torii A, Kodama S. Prognostic significance of entrapped liver cells in hepatic metastases from colorectal cancer. Ann Surg 2000; 232(5):653-57.PubMedCrossRefGoogle Scholar
  11. 11.
    Malafosse R, Penna C, Cunha AS, Nordlinger B. Surgical management of hepatic metastases from colorectal malignancies. Ann Oncol 2001; 12:887-94.PubMedCrossRefGoogle Scholar
  12. 12.
    Pawlik TM, Schlick RD, Choti MA. Expanding criteria for resectability of colorectal liver metastases. Oncologist 2008; 13(1):51-64.PubMedCrossRefGoogle Scholar
  13. 13.
    Tomlinson JS, Jarnagin WR, DeMatteo RP, Fong Y, Kornprat P, Gonen M, Kemeny N, Brennan MF, Blumgart LH, D’Angelica M. Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol 2007; 25(29):4575-80.PubMedCrossRefGoogle Scholar
  14. 14.
    Yamamoto J, Shimada K, Kosuge T, Yamasaki S, Sakamoto M, Fukuda H. Factors influencing survival of patients undergoing hepatectomy for colorectal metastases. Br J Surg 1999; 86:332-37.PubMedCrossRefGoogle Scholar
  15. 15.
    Yamamoto J, Sugihara K, Kosuge T, Takayama T, Shimada K, Yamasaki S, Sakamoto M, Hirohashi S. Pathologic support for limited hepatectomy in the treatment of liver metastases from colorectal cancer. Ann Surg 1995; 221:74-78.PubMedCrossRefGoogle Scholar
  16. 16.
    Lalmahomed ZS, Ayez N, van der Pool AE, Verheij J, IJzermans JN, Verhoef C. Anatomical versus nonanatomical resection of colorectal liver metastases: is there a difference in surgical and oncological outcome? World J Surg 2011; 35:656-61.PubMedCrossRefGoogle Scholar
  17. 17.
    Sarpel U, Bonavia AS, Grucela A, Roavaie S, Schwartz ME, Labow DM. Does anatomic versus nonanatomic resection affect recurrence and survival in patients undergoing surgery for colorectal liver metastasis? Ann Surg Oncol 2009; 16:379-84.PubMedCrossRefGoogle Scholar
  18. 18.
    Yamamoto M, Takasaki K, Ohtsubo T, Katsuragawa H, Fukuda C, Katagiri S. Effectiveness of systematized hepatectomy with Glisson's pedicle transection at the hepatic hilus for small nodular hepatocellular carcinoma: retrospective analysis. Surgery 2001; 130:443-48.PubMedCrossRefGoogle Scholar
  19. 19.
    Hasegawa K, Kokudo N, Imamura H, Matsuyama Y, Aoki T, Minagawa M, Sano K, Sugawara Y, Takayama T, Makuuchi M. Prognostic impact of anatomic resection for hepatocellular carcinoma. Ann Surg 2005; 242:252-59.PubMedCrossRefGoogle Scholar
  20. 20.
    Wakai T, Shirai Y, Sakata J, Kaneko K, Cruz PV, Akazawa K, Hatakeyama K. Anatomic resection independently improves long-term survival in patients with T1-T2 hepatocellular carcinoma. Ann Surg Oncol 2007; 14(4):1356-65.PubMedCrossRefGoogle Scholar
  21. 21.
    Nuzzo G, Giuliante F, Ardito F, Vellone M, Giovannini I, Federico B, Vecchio FM. Influence of surgical margin on type of recurrence after liver resection for colorectal metastases: a single-center experience. Surgery 2008; 143:384-93.PubMedCrossRefGoogle Scholar
  22. 22.
    Wakai T, Shirai Y, Sakata J, Valera VA, Korita PV, Akazawa K, Ajioka Y, Hatakeyama K. Appraisal of 1 cm hepatectomy margins for intrahepatic micrometastases in patients with colorectal carcinoma liver metastasis. Ann Surg Oncol 2008; 15:2472-81.PubMedCrossRefGoogle Scholar
  23. 23.
    Are C, Gonen M, Zazzali K, Dematteo RP, Jarnagin WR, Fong Y, Blumgart LH, D'Angelica M. The impact of margins on outcome after hepatic resection for colorectal metastasis. Ann Surg 2007; 246:295-300.PubMedCrossRefGoogle Scholar
  24. 24.
    Kokudo N, Miki Y, Sugai S, Yanagisawa A, Kato Y, Sakamoto Y, Yamamoto J, Yamaguchi T, Muto T, Makuuchi M. Genetic and histological assessment of surgical margins in resected liver metastases from colorectal carcinoma. Arch Surg 2002; 137:833-40.PubMedCrossRefGoogle Scholar
  25. 25.
    Muratore A, Ribero D, Zimmitti G, Mellano A, Langella S, Capussotti L. Resection margin and recurrence-free survival after liver resection of colorectal metastases. Ann Surg Oncol 2010; 17:1324-29.PubMedCrossRefGoogle Scholar
  26. 26.
    Dhir M, Lyden ER, Wang A, Smith LM, Ullrich F, Are C. Influence of margins on overall survival after hepatic resection for colorectal metastasis: a meta-analysis. Ann Surg 2011; 254:234-42.PubMedCrossRefGoogle Scholar
  27. 27.
    Couinaud C. Surgical anatomy of the liver. Several new aspects. Chirurgie 1986; 112:337-42.Google Scholar
  28. 28.
    Hirokawa F, Hayashi M, Miyamoto Y, Iwamoto M, Tsunematsu I, Asakuma M, Shimizu T, Komeda K, Inoue Y, Tanigawa N. A novel method using the VIO soft-coagulation system for liver resection. Surgery 2011; 149:438-44.PubMedCrossRefGoogle Scholar
  29. 29.
    Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60:646-49.PubMedCrossRefGoogle Scholar
  30. 30.
    Liver Cancer Study Group of Japan. General rules for the clinical and pathological study of primary liver cancer. 3 rd English ed. Tokyo: Kanehara; 2010.Google Scholar
  31. 31.
    Makuuchi M, Hasegawa H, Yamazaki S. Ultrasonically guided subsegmentectomy. Surg Gynecol Obstet 1985; 161:346.PubMedGoogle Scholar
  32. 32.
    Eltawail KM, Mark K, Giovinazzo F, Helmy AH, Salem RR. Differentiating the impact of anatomic and non-anatomic liver resection on early recurrence in patients with hepatocellular carcinoma. World J Surg Oncol 2010; 8:43.CrossRefGoogle Scholar
  33. 33.
    Kaibori M, Matsui Y, Hijikawa T, Uchida Y, Kwon AH, Kamiyama Y. Comparison of limited and anatomic hepatic resection for hepatocellular carcinoma with hepatitis C. Surgery 2006; 139:385-94.PubMedCrossRefGoogle Scholar
  34. 34.
    Dahiya D, Wu TJ, Lee CF, Chan KM, Lee WC, Chen MF. Minor versus major hepatic resection for small hepatocellular carcinoma (HCC) in cirrhotic patients: a 20-year experience. Surgery 2010; 147:676-87.PubMedCrossRefGoogle Scholar
  35. 35.
    Karoui M, Penna C, Amin-Hashem M, Mitry E, Benoist S, Franc B, Rougier P, Nordlinger B. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 2006; 243:1-7.PubMedCrossRefGoogle Scholar
  36. 36.
    Nakano H, Oussoultzoglou E, Rosso E, Casnedi S, Chenard-Neu MP, Dufour P, Bachellier P, Jaeck D. Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy. Ann Surg 2008; 247:118-24.PubMedCrossRefGoogle Scholar
  37. 37.
    Kokudo N, Tada K, Seki M, Ohta H, Azekura K, Ueno M, Matsubara T, Takahashi T, Nakajima T, Muto T. Anatomical major resection versus nonanatomical limited resection for liver metastases from colorectal carcinoma. Am J Surg 2001; 181:153-9.PubMedCrossRefGoogle Scholar
  38. 38.
    Pawlik TM, Scoqqins CR, Zorzi D, Abdalla EK, Andres A, Enq C, Curley SA, Loyer EM, Muratore A, Mentha G, Capussotti L, Vauthey JN. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 2005; 241:715-24.PubMedCrossRefGoogle Scholar
  39. 39.
    Scheele J, Altendorf-Hofmann A, Grube THW, Stangl R, Schmidt K. Resection of colorectal liver metastases: which prognostic factors should govern patient selection? Chirurg 2001; 72:547-60.PubMedCrossRefGoogle Scholar
  40. 40.
    Gayowski TJ, Iwatsuki S, Madariaga JR, Selby R, Todo S, Irish W, Starzl TE. Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery 1994; 116:703-10.PubMedGoogle Scholar
  41. 41.
    Weiss L, Grundmann E, Torhorst J, Hartveit F, Moberg I, Eder M, Fenoqlio-Preiser CM, Napier J, Horne CH, Lopez MJ. Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. J Pathol 1986; 150:195-201.PubMedCrossRefGoogle Scholar
  42. 42.
    Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, Bechstein WO, Primrose JN, Walpole ET, Finch-Jones M, Jaeck D, Mirza D, Parks RW, Collette L, Praet M, Bethe U, Van Cutsem E, Scheithauer W, Gruenberger T; EORTC Gastro-Intestinal Tract Cancer Group; Cancer Research UK; Arbeitsgruppe Lebermetastasen und-tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie (ALM-CAO); Australasian Gastro-Intestinal Trials Group (AGITG); Fédération Francophone de Cancérologie Digestive (FFCD). Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 2008; 371(9617):1007-16PubMedCrossRefGoogle Scholar
  43. 43.
    Meyerhardt JA, Mayer RJ. Systemic therapy for colorectal cancer. N Engl J Med 2005; 352:476-87.PubMedCrossRefGoogle Scholar
  44. 44.
    Scheele J, Stang R, Altndorf-Hofmann A, Paul M. Resection of colorectal liver metastasis. World J Surg 1995; 19:59-71.PubMedCrossRefGoogle Scholar

Copyright information

© The Society for Surgery of the Alimentary Tract 2012

Authors and Affiliations

  • Yoshihiro Inoue
    • 1
  • Michihiro Hayashi
    • 1
  • Koji Komeda
    • 1
  • Shinsuke Masubuchi
    • 1
  • Masashi Yamamoto
    • 1
  • Hidenori Yamana
    • 1
  • Hajime Kayano
    • 1
  • Tetsunosuke Shimizu
    • 1
  • Mitsuhiro Asakuma
    • 1
  • Fumitoshi Hirokawa
    • 1
  • Yoshiharu Miyamoto
    • 1
  • Atsushi Takeshita
    • 2
  • Yuro Shibayama
    • 2
  • Kazuhisa Uchiyama
    • 1
  1. 1.Department of General and Gastroenterological SurgeryOsaka Medical College HospitalOsakaJapan
  2. 2.Department of PathologyOsaka Medical College HospitalTakatsukiJapan

Personalised recommendations